PMID

Data

Article Title

Organization

Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.

The University of Mississippi

Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors.

The University of Mississippi

Cytotoxicity and modulation of cancer-related signaling by (Z)- and (E)-3,4,3',5'-tetramethoxystilbene isolated from Eugenia rigida.

The University of Mississippi

5-OHKF and NorKA, depsipeptides from a Hawaiian collection of Bryopsis pennata: binding properties for NorKA to the human neuropeptide Y Y1 receptor.

The University of Mississippi

Design, synthesis, and docking studies of novel benzimidazoles for the treatment of metabolic syndrome.

The University of Mississippi

Kinetic studies and bioactivity of potential manzamine prodrugs.

The University of Mississippi

2-N-Methyl modifications and SAR studies of manzamine A.

The University of Mississippi

Conversion of a highly selective sigma-1 receptor-ligand to sigma-2 receptor preferring ligands with anticocaine activity.

The University of Mississippi

Synthesis and pharmacological evaluation of indole-based sigma receptor ligands.

The University of Mississippi

Benzyl derivatives with in vitro binding affinity for human opioid and cannabinoid receptors from the fungus Eurotium repens.

The University of Mississippi

Biologically active compounds from Aphyllophorales (polypore) fungi.

The University of Mississippi

New antiinfective and human 5-HT2 receptor binding natural and semisynthetic compounds from the Jamaican sponge Smenospongia aurea.

The University of Mississippi

Neocosmospora sp.-derived resorcylic acid lactones with in vitro binding affinity for human opioid and cannabinoid receptors.

The University of Mississippi

Chemical and biological investigation of the fungus Pulveroboletus ravenelii.

The University of Mississippi

Bioactive products from singlet oxygen photooxygenation of cannabinoids.

The University of Mississippi

Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases

Merck Sharp & Dohme

N2,N4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer

Korea Research Institute of Chemical Technology